Press release
Hypoxia-Inducible Factor (HIF) Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results | FibroGen, Inc.
Download the sample report @ https://www.pharmaproff.com/enquiry/1139
In conditions like wounds, hypoxia mediate the migration of keratinocytes and restores the epithelium. According to the researchers, the HIF plays a vital role in the development of human body, as they are required by the body to adapt in low oxygen concentration and maintain the metabolism.
Get the detailed analysis @ https://www.pharmaproff.com/report/hif-inhibitor-therapeutics-pipeline-analysis
The therapeutic candidate which acts as an HIF inhibitor has been found to improve the symptoms in anemia, inflammatory disorders and cancer. In addition, HIF inhibitor have also been found to increase the erythropoietin expression and enhance hippocampal memory. In addition, HIF is also essential for immunological responses and is a key physiological regulator of homeostasis, vascularization, and anaerobic metabolism.
Make enquiry before purchase @ https://www.pharmaproff.com/request-sample/1139
Company like FibroGen Inc. is developing roxadustat as a HIF prolyl hydroxylase inhibitor for the treatment of anemia in chronic kidney disease (CKD) and myelodysplastic syndrome (MDS).
• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hypoxia-Inducible Factor (HIF) Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results | FibroGen, Inc. here
News-ID: 1729744 • Views: …
More Releases for HIF
Advancement In Oral HIF-2α Inhibitors For Paraganglioma Treatment Trend: A Cruc …
What industry-specific factors are fueling the growth of the paraganglioma market?
The increasing investments in oncology research and medicine are expected to propel the growth of the paraganglioma market. These investments, made by governments, pharmaceutical companies, research institutions, and private investors, focus on advancing the understanding, prevention, diagnosis, and treatment of cancer. The rise in global cancer cases, advancements in precision medicine, growing demand for innovative therapies, expanding clinical trials, and…
Methanol to Jet Fuel Market Trends and Growth Opportunities to 2025 | Honeywell, …
Los Angeles, United State: The report titled, "Global Methanol to Jet Fuel Market Research Report 2025" is recently published by QY Research. The analysts and researchers have performed primary as well as secondary research on a large scale with the help of various methodologies like Porter's Five Forces and PESTLE Analysis. Key trends and opportunities that may emerge in the near future have been discussed in the Methanol to…
Electronic Sustainable Aviation Fuel (ESAF) Market Top Players - Honeywell, HIF …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Sustainable Aviation Fuel (ESAF) Market - (By Type (Sustainable Aviation Biofuels, Sustainable Aviation Synthetic Fuel), By Application (Civil Aviation, Military)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.
According to the latest research by InsightAce Analytic, the Global Electronic Sustainable Aviation Fuel (ESAF) Market is expected to expand with a CAGR of 48.2% during…
Synthetic Gasoline Market Gears Up for Strong Growth in 2024: Trends and Analysi …
Los Angeles, USA: QY Research has recently unveiled a comprehensive report titled, "Global Synthetic Gasoline Market Report: Insights, Forecast to 2030." This detailed analysis examines the multiple elements shaping the future of the global Synthetic Gasoline market.
The Synthetic Gasoline report serves as an invaluable resource for industry players, providing precise and extensive research insights necessary for strategic decision-making. The analysts have conducted an in-depth segmental evaluation based on type, application,…
Trending: E-Fuel Market to Witness Robust Growth in the Coming Years | Sunfire, …
The Global E-Fuel market research report 2023 provides an in-depth analysis of an industry or market, covering essential aspects such as market size, growth potential, competitive landscape, consumer behaviour, and other significant factors influencing the market.
This report is a valuable resource for businesses seeking to enter or expand their presence in the market, as it enables them to make informed strategic decisions. Ultimately, the E-Fuel market research report is a…
Global Renal Anemia Treatment Market 2023: Development of Novel HIF Stabilizers …
The renal anemia treatment market refers to the industry that produces and sells drugs and therapies used to treat anemia caused by chronic kidney disease (CKD). Renal anemia is a common complication of CKD and is characterized by a decrease in red blood cells caused by a deficiency in erythropoietin (EPO) production. The market for renal anemia treatment is expected to grow due to the increasing prevalence of CKD and…
